Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296790 · ClinicalTrials.gov registry record · Phase 4
Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)
A Phase 4 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 4
- Development phase
- 372
- Enrollment target
NCT00296790 is a Phase 4 study that has completed, run by Sanofi. The registered enrollment target is 372 participants.
The verdict
NCT00296790, a Phase 4 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 372 participants
- Enrollment target
Study Summary
A comparison of Zolpidem Tartrate Extended-Release (Ambien CR)vs. Placebo in the Treatment of Insomnia Associated with Generalized Anxiety Disorder (GAD) when Used Concomitantly with Escitalopram (Lexapro - antidepressant).
Interventions
- DRUG zolpidem tartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00296790
The ClinicalTrials.gov registry entry for NCT00296790 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 372 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which zolpidem tartrate is the first listed.
NCT00296790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00296790 about?
NCT00296790 is a clinical study titled "Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)". A comparison of Zolpidem Tartrate Extended-Release (Ambien CR)vs. Placebo in the Treatment of Insomnia Associated with Generalized Anxiety Disorder (GAD) when Used Concomitantly with Escitalopram (Lexapro - antidepressant).
What is the current status of trial NCT00296790?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 372 participants. The study started on 2006-02. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00296790?
The interventions under investigation include: zolpidem tartrate (DRUG).
Who is sponsoring clinical trial NCT00296790?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.